About Getreal Initiative

Launched in June 2018, the GetReal Initiative is a two-year project of the Innovative Medicines Initiative (IMI), a EU public-private consortium consisting of pharmaceutical companies, academia, HTA agencies and regulators, patient organisations and SMEs. The ultimate goal is to drive the adoption of tools, methodologies and best practices from IMI GetReal and increase the quality of real-world evidence (RWE) generation in medicines development and regulatory/HTA processes across Europe.

This will be achieved through:

Adoption and sustainability
Optimising and ensuring the adoption and sustainability of the tools and frameworks developed under GetReal.
RWE research community
Creating a leading RWE research community partnership on science and innovation in RWE
Establishing a small self-sustaining unit
A not-for-profit unit which ensures that the tools, knowledge and educational materials generated in GetReal will remain available.

THE MAIN WORKING GROUPS

THINK TANK

Thought leaders in RWE Research

READ MORE >>

Task Force A

Pragmatic Trials and Statistics for Enriched Trials

READ MORE >>

Task Force B

Network meta-analysis and indirect comparisons

READ MORE >>

Work Package 2

Long term sustainability of the GetReal Initiative on a not-for-profit basis

READ MORE >>

The GetReal Initiative Consortium

The consortium consists of 16 partners and is built on the original IMI GetReal consortium. The consortium brings together the critical expertise needed, with experts from academia, HTA bodies, industry and patient organisations, among others.

OUR PARTNERS
»

The GetReal Initiative project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 807012. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.